Modern computational intelligence based drug repurposing for diabetes epidemic

Objectives are to explore recent advances in discovery of new antidiabetic agents using repurposing strategies and to discuss modern technologies used for drug repurposing highlighting diabetic specific web portal.Recent literature were studied and analyzed from various sources such as Scopus, PubMed, and IEEE Xplore databases.Drugs like Niclosamideethanolamine, Methazolamide, Diacerein, Berberine, Clobetasol, etc. with possibility of repurposing to curb diabetes can be potential late-stage clinical candidates, providing access to information on pharmacology, formulation, and probable toxicity if any.With collaboration of artificial intelligence (AI) with pharmacology, the efficiency of drug repurposing can improve significantly.